Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2026
Seventh Åland Island Meeting on von Willebrand DiseaseRiitta Lassila, Ruben Bierings, Nathan T Connell, et al.
Therapeutic Advances in Hematology|May 8, 2026
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS StudyDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Blood|July 3, 2025
Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS TrialDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Frontiers in Immunology|September 5, 2019
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic CellsMarco Gargaro, Carmine Vacca, Serena Massari, et al.
The New England Journal of Medicine|July 12, 2026
Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee ArthroplastySudeep Shivakumar, Davide Matino, David Zukor, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2020
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammationGiada Mondanelli, Alice Coletti, Francesco Antonio Greco, et al.
The Journal of Clinical Investigation|October 2, 2015
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIIIDavide Matino, Marco Gargaro, Elena Santagostino, et al.
Research and Practice in Thrombosis and Haemostasis|November 19, 2024
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction modelIlja Oomen, Amal Abdi, Ricardo M Camelo, et al.
JCI Insight|March 23, 2018
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetesCiriana Orabona, Giada Mondanelli, Maria T Pallotta, et al.
Nature|June 17, 2014
Aryl hydrocarbon receptor control of a disease tolerance defence pathwayAlban Bessede, Marco Gargaro, Maria T Pallotta, et al.
Pageof 7